Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

Is ketamine a breakthrough ... Marketed as Spravato, it’s a nasal spray. While it’s been available for three years, it’s not widely used--perhaps because it must be administered in a ...

Ketamine is now administered in different forms—such as intravenous (IV) infusion, nasal spray, or oral lozenges—to treat ...

Right now Ketamine is not FDA approved to treat any psychiatric disorder. But back inJuly, Johnson and Johnson did seek approval for a nasal Ketamine spray, that is currently in waiting.

He went for an appointment this week, only to find the clinic closed. "I do know some guys that take [es]ketamine for PTSD. It's helped them immensely." Veterans use the nasal spray esketamine to ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...

Ketamine, an anesthetic ... Company researchers synthesized a version, called esketamine. They made it into a nasal spray to ...

"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

The most obvious, he says, appears to be the availability of Nalaxone, or Narcan, which is a nasal spray that can reverse an opioid overdose. Watch: Doctor who supplied Matthew Perry ketamine ...

In 2019, VistaGen reported that its ketamine-like drug AV-101B failed ... VistaGene meanwhile is also developing PH10, another pherine nasal spray heading for a phase 2b study in MDD.